Tiziana Life Sciences Ltd (TLSA)

Tiziana Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	7.25	3.72	1.18
Cash & Short-Term Investments	7.25	3.72	1.18
Cash Growth	541.68%	214.79%	-
Accounts Receivable	4.88	3.61	2.14
Other Receivables	0.07	0.03	3.79
Total Trade Receivables	4.95	3.64	5.93
Other Current Assets	0.52	0.15	0.22
Total Current Assets	12.72	7.51	7.34
Net Property, Plant & Equipment	0.15	0.19	0.29
Long-Term Investments	3.73	3.59	4.55
Total Assets	16.6	11.28	12.18
Accounts Payable	7.18	7.23	6.39
Current Portion of Leases	0.11	0.11	0.14
Other Current Liabilities	0.01	0.01	0.01
Total Current Liabilities	7.4	7.35	6.54
Long-Term Leases	-	-	0.11
Total Long-Term Liabilities	-	-	0.11
Total Liabilities	7.4	7.35	6.65
Common Stock	0.12	0.11	0.1
Treasury Stock	-	-	-1.57
Additional Paid-in Capital	160.91	150.36	142.32
Accumulated Other Comprehensive Income	-1.37	-1.71	-1.64
Retained Earnings	-150.46	-144.83	-133.68
Shareholders' Equity	9.2	3.94	5.54
Total Liabilities & Equity	16.6	11.28	12.18
Total Debt	0.11	0.11	0.25
Net Cash (Debt)	7.14	3.62	0.94
Net Cash Growth	97.46%	286.54%	-
Net Cash Per Share	0.32	0.17	0.05
Book Value	9.2	3.94	5.54
Book Value Per Share	0.41	0.18	0.27
Tangible Book Value	9.2	3.94	5.54
Tangible Book Value Per Share	0.41	0.18	0.27

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q